1Diamandis EP, Bast RC Jr, Gold P,et al. Reflection onthe discovery of carcinoembryonic antigen?prostate-spe-cific andgen,and cancer antigens CA125 and CA] 9-9[J].Clin Chem,2013,59(1):22-31.
2Nielsen HJ, Brunner N, Jorgensen LN, et al. PlasmaTIMP-1 and CEA in detection of primary colorectalcancer: a prospective> population based study of 4509high-risk individuals[J].Scand J Gastroenterol, 2011,46(1):60-69.
3Lee SY, Min KS,Chung JK,et al.Carcinoembryonic anti-gen level of draining venous blood as a predictor of re-currence in colorectal cancer patient [J].J Korean SurgSoc,2011,81(6);387-393.
4Kanellos I,Zacharakis E, Kanellos D,et al. Prognosticsignifi-cance of CEA levels and detection of CEA mR-NA in draining venous blood in patients with colorectalcancer[J].J Surg Oncol, 2006,94(1):3-8.
5Nozoe T,Rikimaru T,Mori E, et al. Increase in bothindicator in colorectal carcinoma[J].J Surg Oncol,2006,94(2):132-137.
6National Comprehensive Cancer Network.NCCN ClinicalPractice Guidelines in Oncology[M].Colon Cancer Ver-sion 3.
7American Joint Committee on Cancer. AJCC CancerStaging Manual [M]. New York,NY: American JointCommittee on Cancer,2010.
8Reiter W’Stieber P,Reuter C,et al.Multivariate analysisof the prognostic value of CEA and CA19-9 serum levelsin colorectal cancer[J]. Anti Cancer Res. 2000 , 20 ( 6D):5195-5198.
10Nakatani H? Kumon T, Kumon M, et al. High serumlevels of both carcinoembryonic antigen and carbohy-drate antigen 19-9 in a patient with sigmoid colon canc-er without mertastasis[J].J Med Invest,2012,59(3-4):280-283.
3Konstadoulakism M,Syr igos K,Albanopoulos C,et al.The p resence of anti-carcinoembryonic antigen(CEA)andtibodies in the sera of patients with GImalignancies[J].J ClinImmunol,1994,14(5):310-313.
4Haidopoulos D,Konstadoulakism M,Antonakis PT,etal.Circulating anti-CEA antibodies in the sera of patientswith breast cancer[J].Eur J SurgOncol,2000,26(8):742–746.
